Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CNR1 Protein

MNP Membrane Nanoparticle CNR1-Protein exprimiert in Mammalian Cells.
Produktnummer ABIN7538158

Kurzübersicht für CNR1 Protein (ABIN7538158)

Target

Alle CNR1 Proteine anzeigen
CNR1 (Cannabinoid Receptor 1 (CNR1))

Protein-Typ

MNP Membrane Nanoparticle

Spezies

  • 11
  • 3
  • 1
Human

Quelle

  • 7
  • 3
  • 3
  • 2
Mammalian Cells
  • Verwendungszweck

    Human CB1 full length protein membrane nanoparticles (MNPs)

    Produktmerkmale

    Plasma membrane-coated nanoparticles (MNPs) have been used in various applications, including delivery of therapeutic agents and induction of immune responses et al. Unlike the conventional strategies, MNPs directly leverage intact and natural functions of cell membranes, and show high biocompatibility, specificity, and low side effects. Our optimized MNPs platform for the full-length membrane protein production uses membrane coating technology and a HEK293 based expression platform. The high-purity plasma membrane-coated nanoparticles were produced by extrusion after membrane extraction from the host HEK293 cells containing the overexpressed target proteins.
  • Möchten Sie weitere Optionen für dieses Protein ?

    !
    Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!
    Produkt
    Expressionssystem
    Konjugat
    Origin
    Preis ab
    Expressionssystem HEK-293 Cells
    Konjugat His tag
    Origin Human
    Preis ab 16.256,82 €
    Expressionssystem Cell-free protein synthesis (CFPS)
    Konjugat Strep Tag
    Origin Human
    Preis ab 15.754,29 €

    Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen

  • Kommentare

    Advantages of Membrane Nanoparticles (MNPs):

    • High display density of target membrane proteins
    • Native structure and orientation of transmembrane protein
    • soluble in aqueous solutions for routine biochemical analysis
    • Detergent-free purification process
    • Strong immunogenicity
    • Works for MPs that can´t be produced via VLPs and EXos
    Limitations of Membrane Nanoparticles (MNPs):
    • Lack of accurate quantification of the target membrane proteins.
    • Need to develop special SPR assayx.
    • Cell membranes contain housekeeping proteins that can result in immune response dilution.
    • Some membrane proteins can´t be enriched on membrane.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    Haltbarkeit

    12 months
  • Target

    CNR1 (Cannabinoid Receptor 1 (CNR1))

    Andere Bezeichnung

    CB1

    Hintergrund

    The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene.

    Molekulargewicht

    The human full length CB1 Protein has a MW of 52.7 kDa

    UniProt

    P21554

    Pathways

    Feeding Behaviour
Sie sind hier:
Chat with us!